| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/03/2012 | CA2517705C Method for labeling phosphorylated peptides, method for selectively adsorbing phosphorylated peptides, complex compounds used in the methods, process for producing the complex compounds, and raw material compounds for the complex compounds |
| 01/03/2012 | CA2466538C System for degassing muds and for analysing the gases contained in the muds |
| 01/03/2012 | CA2455393C Functional surface coating |
| 01/03/2012 | CA2445102C Method and means for detecting gluten-induced diseases |
| 01/03/2012 | CA2436049C A serpin in bifidobacteria |
| 01/03/2012 | CA2425202C Immunoreactive peptide ctl epitopes of human cytomegalovirus pp150 |
| 01/03/2012 | CA2420949C Peptide selection method |
| 01/03/2012 | CA2413258C Interferon-like protein zcyto21 |
| 01/03/2012 | CA2407744C Quantitative multiplex pcr with high dynamic range |
| 01/03/2012 | CA2388180C Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 01/03/2012 | CA2378574C Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-cd20 antibody |
| 01/03/2012 | CA2375034C Method and device for analysis of biological specimens |
| 01/03/2012 | CA2366433C Staphylococcus antigen and vaccine |
| 01/03/2012 | CA2348698C Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| 01/03/2012 | CA2337490C Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
| 01/03/2012 | CA2258348C Screening compounds for the ability to alter the production of amyloid-.beta. peptide (x-.gtoreq.41) |
| 01/03/2012 | CA2248893C Graphitic nanotubes in luminescence assays |
| 01/03/2012 | CA2242414C Anti-cd18 antibodies for use against stroke |
| 12/29/2011 | WO2011163566A2 Methods of treating patients with immune-related diseases |
| 12/29/2011 | WO2011163558A1 Materials and methods for assay of anti-hepatitis c virus (hcv) antibodies |
| 12/29/2011 | WO2011163554A2 Lipocalin-type prostaglandin d2 synthase as a biomarker for lung cancer progression and prognosis |
| 12/29/2011 | WO2011163506A2 Methods and kits for predicting a response to an erythropoietic agent |
| 12/29/2011 | WO2011163497A2 Method for determining predisposition to esophageal-related disorders |
| 12/29/2011 | WO2011163478A2 Dual variable domain immunoglobulins and uses thereof |
| 12/29/2011 | WO2011163476A2 Colorimetric method and device for detecting analyte quantities in fluids and materials |
| 12/29/2011 | WO2011163448A1 A device for monitoring a patient for a urinary tract infection |
| 12/29/2011 | WO2011163423A2 Methods and compositions for cell permeable stat3 inhibitor |
| 12/29/2011 | WO2011163370A2 Analysis of microneutralization assay using curve-fitting constraints |
| 12/29/2011 | WO2011163340A1 Reduction in false results in assay measurements |
| 12/29/2011 | WO2011163332A2 Methods for detecting cancer |
| 12/29/2011 | WO2011163320A2 Method and apparatus for detecting and regulating vascular endothelial growth factor (vegf) by forming a homeostatic loop employing a half-antibody biosensor |
| 12/29/2011 | WO2011163258A2 Compositions and methods for diagnosing and monitoring disease and treatment via antigen-specific molecules |
| 12/29/2011 | WO2011162878A1 Method for adjusting concrete rheology based upon nominal dose-response profile |
| 12/29/2011 | WO2011162847A2 Stress-based sensor, method and applications |
| 12/29/2011 | WO2011162821A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 12/29/2011 | WO2011162820A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 12/29/2011 | WO2011162819A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 12/29/2011 | WO2011162805A2 Prion inactivation using ozone |
| 12/29/2011 | WO2011162635A1 Method for non-invasive potentiometric determination of the oxidant/antioxidant activity of biological tissues and device for implementing same |
| 12/29/2011 | WO2011162603A1 Method for determining one or more characterizing features of a macromolecule and an apparatus for carrying out said method |
| 12/29/2011 | WO2011162563A2 Disease marker detection kit and disease marker detection method |
| 12/29/2011 | WO2011162492A2 Fusion protein comprising small heat shock protein, cage protein formed thereby, and novel use thereof |
| 12/29/2011 | WO2011162317A1 Method for determination or evaluation of substance of interest |
| 12/29/2011 | WO2011162295A1 Detection method for novel ros1 fusion product |
| 12/29/2011 | WO2011162150A1 Fluorescence measurement method |
| 12/29/2011 | WO2011161960A1 C1orf59 for target genes of cancer therapy and diagnosis |
| 12/29/2011 | WO2011161933A1 Method for detection of urothelial cancer |
| 12/29/2011 | WO2011161895A1 Process for production of analysis element chip |
| 12/29/2011 | WO2011161697A1 Method and apparatus for assessing lubricity of cutting fluids |
| 12/29/2011 | WO2011161630A1 Highly specific antibodies, composition and methods thereof |
| 12/29/2011 | WO2011161628A2 Method for screening compounds for treatment of tumors bearing activated oncogenes and compounds thereof |
| 12/29/2011 | WO2011161611A1 Method for selecting mevalonate synthesis modulators using cells derived from human pluripotent cells |
| 12/29/2011 | WO2011161544A2 Biomarker for fatigue, and use thereof |
| 12/29/2011 | WO2011161438A2 Biomarkers |
| 12/29/2011 | WO2011161436A2 Prevention of proteomic and genomic damage by dicarbonyl substrates of glo 1 |
| 12/29/2011 | WO2011161430A1 Assay for detecting frre light chains by capillary zone electrophoresis |
| 12/29/2011 | WO2011161422A1 Bioactive glass composition |
| 12/29/2011 | WO2011161414A1 Analyte sensor |
| 12/29/2011 | WO2011161253A1 Editing profiling of pde8a pre -mrna : use as specific biomarker of adars activities in human tissues to diagnose and to predict and assess therapeutic efficacy and/or efficiency or potential drug side effects |
| 12/29/2011 | WO2011161186A1 Method for in vitro diagnosing sepsis utilizing biomarker composed of more than two different types of endogenous biomolecules |
| 12/29/2011 | WO2011161150A1 Method for the characterization of intermolecular interactions |
| 12/29/2011 | WO2011161062A2 Lipidomic biomarkers for identification of high-risk coronary artery disease patients |
| 12/29/2011 | WO2011160989A1 Nano-fluidic field effective device to control dna transport through a nano channel comprising a set of electrodes |
| 12/29/2011 | WO2011160899A1 Test method for a humidity sensor and sensor module therefor |
| 12/29/2011 | WO2011160866A1 Cell monitoring by means of scattered light measurement |
| 12/29/2011 | WO2011160845A2 Oxidized phospholipids and lipoproteins, and antibodies thereto, as biomarkers of inflammatory conditions and methods of treatment |
| 12/29/2011 | WO2011160827A2 Novel jnk inhibitor molecules |
| 12/29/2011 | WO2011160653A1 Novel jnk inhibitor molecules |
| 12/29/2011 | WO2011160237A1 Genetic markers associated with intellectual disability |
| 12/29/2011 | WO2011160206A1 Biomarkers for non-hodgkin lymphomas and uses thereof |
| 12/29/2011 | WO2011160187A1 An absorption probe for measuring dissolved organic carbon in an aqueous sample |
| 12/29/2011 | WO2011160174A1 Treatment of proliferative diseases |
| 12/29/2011 | WO2011160168A1 Rheometry instrument utilizing surface acoustic waves |
| 12/29/2011 | WO2011138778A3 Methods of identifying inhibitors of polypeptides-of-interest |
| 12/29/2011 | WO2011138592A3 Devices and mehtods for testing analytes |
| 12/29/2011 | WO2011136527A9 Nanofluidic fluorescence apertureless near-field scanning optical miscroscope |
| 12/29/2011 | WO2011135194A3 Method for diagnosing risk of type 1 diabetes and for preventing onset of type 1 diabetes |
| 12/29/2011 | WO2011135127A3 Improved miniature extraction device |
| 12/29/2011 | WO2011132182A9 MOLECULES AND METHODS OF USING SAME FOR TREATING ErbB/ErbB LIGANDS ASSOCIATED DISEASES |
| 12/29/2011 | WO2011123166A3 Methods and systems for reducing dna fragmentation in a processed sperm sample |
| 12/29/2011 | WO2011103182A3 Imaging methods for assessment and quantification of vaccination and in vivo antigen capture |
| 12/29/2011 | WO2011100595A3 Methods and devices for sample collection, treatment and dispensing |
| 12/29/2011 | WO2011100396A3 Serum clusterin levels in systemic amyloidosis featuring cardiomyopathy |
| 12/29/2011 | WO2011100374A3 Mediator and cohesin connect gene expression and chromatin architecture |
| 12/29/2011 | WO2011100253A3 Carbon quantifying apparatus and method |
| 12/29/2011 | WO2011096698A3 Composition for cancer prognosis prediction comprising anti-tmap/ckap2 antibodies |
| 12/29/2011 | WO2011094692A3 Systems and methods for collecting and depositing particulate matter onto tissue samples |
| 12/29/2011 | WO2011094572A3 Hanging drop devices, systems and/or methods |
| 12/29/2011 | WO2011090351A3 Diagnostic method and diagnosing kit for prostatitis |
| 12/29/2011 | WO2011088128A3 Methods for biomolecule and biomolecule complex (bmc) detection and analysis and the use of such for research and medical diagnosis |
| 12/29/2011 | WO2011087916A3 Force mediated assays |
| 12/29/2011 | WO2011085163A3 Protein markers for lung cancer detection and methods of using thereof |
| 12/29/2011 | WO2011072247A3 Pathogen restriction factors |
| 12/29/2011 | WO2011058529A4 Method and system for the real-time automatic analysis of the quality of samples of processed fish meat based on the external appearance thereof, said samples travelling on a conveyor belt such that surface defects can be detected and the fish meat can be sorted according to quality standards |
| 12/29/2011 | WO2011056975A4 Genetically encoded calcium indicators and methods of use |
| 12/29/2011 | WO2010136759A8 Method and system for analyzing calcium transients in coupled cells |
| 12/29/2011 | WO2010038579A8 Process for producing microbeads and microbeads |
| 12/29/2011 | WO2009121152A8 Gene signatures |
| 12/29/2011 | US20110321197 Plants with Increased Yield (NUE) |
| 12/29/2011 | US20110319602 T2r taste receptors and genes encoding same |